-
European Psychedelics Research Group Nabs $2M In Seed Funding As Clinical Research Picks Up Speed
Tuesday, October 11, 2022 - 5:07pm | 615Read More...UK psychedelics clinical research organization Clerkenwell Health raised $2.047.710 (£2.1 million) in seed funding, bringing the total to date up to $2.437.750 (£2.5 million), all of which will be used to get the London-based startup fully operational. Investors of the seed funding...
-
Magic Mushrooms Vs. Psychotherapy For Incurable Cancer Diagnosis Moves Forward In UK Clinical Trials
Monday, September 19, 2022 - 12:59pm | 562Read More...UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Psyence Group Inc. (OTCQB: PSYGF)’s application to assess the efficacy and safety of psilocybin-assisted psychotherapy compared to psychotherapy alone for treating adjustment disorder following an incurable...
-
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
Wednesday, September 14, 2022 - 2:26pm | 418Read More...Biotech drug discovery firm Mindset Pharma Inc. (OTCQB: MSSTF) develops next-generation psychedelic and non-psychedelic medicines for neuropsychiatric and neurological disorders. To pursue their goal it received scientific advice from the UK Medicines and Healthcare Products Regulatory Agency...
-
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
Monday, September 13, 2021 - 1:37pm | 1768Read More...Last Week In Psychedelics: CaamTech Raises $22M With A Broad Portfolio Of Novel Psychedelic Drugs Octarine Bio and Clerkenwell Health Partner Up For Clinical Trials Mydecine To Launch Smoking Cessation Clinical Trial With Johns Hopkins University DMT Found To Stimulate Growth Of...
